Company ProfilePremium

Tassal Group Limited

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Tassal Group Limited - Company showcase

Year Founded & Workforce

1986

1,712 Employees

Tassal Group Limited logo

Tassal Group Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Tassal Group Limited Overview

Tassal is Australia's largest vertically integrated aquaculture-led seafood business and was, until 2026, Tasmania's largest Atlantic salmon producer by volume. It runs freshwater hatcheries, marine farms, processing plants and branded sales channels for Tasmanian Atlantic salmon. It has diversified into Queensland black tiger prawns under the Tropic Co brand, ocean-farmed barramundi at Cone Bay in Western Australia (acquired 2023), and seafood wholesaling and retail through De Costi Seafoods in Sydney. After three decades as a home-grown company and 19 years on the ASX, Tassal was acquired by Canada's Cooke Inc. in November 2022 for about A$1.7bn in enterprise value. That deal made it Cooke's first and largest-ever investment, and Cooke's Australian platform. Tassal's competitive franchise rests on scarce marine lease access, scale in domestic retail, and its brand. The operating environment since 2025 has been defined by warming waters, endemic Piscirickettsia salmonis disease, antibiotic controversy, Macquarie Harbour environmental politics, and the loss of its top-producer ranking to JBS-owned Huon Aquaculture.


Company's own description

In its final ASX-era materials (SID announcement, August 2022; Annual Report 2022), Tassal described itself as a vertically integrated salmon and prawn grower, and a salmon, prawn and seafood processor, seller and marketer. In the Cooke merger release it was described as Australia's largest vertically integrated seafood producer and "blue agri-tech" business.

Its stated purpose after the acquisition, used in the 2023 barramundi announcement, is "Sustainably Feeding Tomorrow". Earlier corporate messaging focused on growing domestic per-capita consumption of salmon and prawns through brand building.

Independent characterisation

Tassal is a biological-asset-intensive protein producer. It controls nearly the whole value chain:

  1. Genetics and smolt. Access to the Tasmanian industry selective-breeding programme run by SALTAS; company hatcheries, including the Rookwood nursery, where smolt spend 8–12 months before sea transfer. FY2019 plans included a multi-purpose recirculating aquaculture system (RAS) smolt facility budgeted at about A$46m.

  2. Grow-out. Marine leases in south-east Tasmania (Huon/D'Entrecasteaux Channel, Bruny Island and Great Taylors Bay, Tasman Peninsula including Long Bay, Storm Bay, Okehampton Bay/Mercury Passage) and the west coast (Macquarie Harbour). The ABC reported in August 2026 that Tassal holds 18 marine farm environmental licences, four freshwater hatcheries and four processing sites in Tasmania.

  3. Processing. Fresh whole fish, fillets and portions, smoked and value-added products.

  4. Marketing and distribution. Branded retail (major supermarkets), foodservice ("out-of-home"), wholesale, export (especially Asia), and the De Costi Seafoods retail/wholesale business in NSW.

Revenue model. Almost entirely product sales of farmed and traded seafood. There is no material service, subscription or licensing revenue. Statutory results also carry fair-value adjustments on biological assets (AASB 141). This is why Tassal historically reported both "statutory" and "operating" (excluding fair-value and one-off items) earnings.

Customer types.

  • Australian supermarket chains (retail)

  • Foodservice and restaurants

  • Seafood wholesalers

  • De Costi retail customers

  • Export customers (Asia-focused in FY2022). Exports were 20.3% of total sales in 1H FY2020 (company 1H20 results, reported by The Motley Fool)

End markets. Australian retail seafood (dominant), Australian foodservice, export salmon (opportunistic, price-driven), and the domestic premium prawn and barramundi markets.

Strategy

Final ASX-era strategy (Annual Report 2022 themes, paraphrased)

  • Tassal described itself as having reached scale after a heavy investment cycle, freeing it to emphasise cash flow and shareholder returns.

  • With incremental biomass funding no longer needed, growth would come from sales mix, cost optimisation, product innovation and brand building.

  • Leverage unique assets: lease positions, hatcheries, processing, and the De Costi channel.

  • Grow domestic per-capita consumption of salmon and prawns.

  • Transfer salmon know-how to prawns.

  • Targeted dividend payout of at least 50% of operating NPAT (1H22 release).

  • Responsible Business Blueprint and ambition to be one of the world's most transparent and sustainable protein producers.

Cooke-era stated intentions (Aug–Nov 2022)

Cooke's stated plans at acquisition were to:

  • Keep existing operations management in place.

  • Make strategic investments in engineering, science and technology.

  • Expand Tassal's sales reach through Cooke's global distribution network.

  • Prioritise collaboration with other producers and regulators on continuous environmental improvement.

Initiatives in the last 24 months (Oct 2024–Oct 2026)

InitiativeDateDetailSource
Florfenicol medicated-feed treatments under APVMA emergency permitNov 2025–Mar 2026Industry used florfenicol 13 times between early Nov 2025 and late Jan 2026. Tassal treated GTB2 from 24 Jan to 2 Feb 2026 and started treatments at five leases around 22 Feb 2026Fish Farming Expert; Tasmanian Greens; Tasmanian Country
Application for florfenicol at Okehampton BayEarly 2026Noted in a Legislative Council motionRosemary Armitage MLC, 24 Mar 2026
Industry campaign "Tasmanians Depend on Salmon" (via Salmon Tasmania)Apr 2026Advertising campaign built on testimonials from workers in businesses that depend on the industryABC News, 22 Apr 2026
Long Bay lease continuationAug 2026Two-year EPA extensionABC News
At-sea oxytetracycline injectionsOct 2026Each fish is anaesthetised, injected, monitored and returned to its pen. Tassal says this uses a fraction of the medicine needed for medicated feed and that environmental exposure is expected to be low, localised and short-livedABC; Pulse Tasmania; LAFM
Climate-risk disclosure2,026Tassal's climate report estimates 1°C of warming would raise mortality from 15 to 18.5 fish per 100UTS ISF report via Mirage News / Port News, Oct 2026

Medium-term targets

Not publicly disclosed since delisting. The last public targets were:

  • A sustainable salmon harvest of about 40,000 HOG t from existing leases (1H22).

  • A payout ratio of at least 50% of operating NPAT. This is now irrelevant under private ownership.

Products & Services

Salmon (Tasmanian Atlantic salmon)

Brand / lineDescriptionTarget customerNotes
Tassal (master brand)Fresh Tasmanian Atlantic salmon: whole fish, fillets, portions, skin-on/skinless retail packsSupermarket shoppers, foodserviceCore brand. FY2021 strategy focused on "Tassal branded retail"
Tassal Superior Gold / Tassal Chef Selection Superior GoldPremium salmon line, reportedly relaunched as "Tassal Chef Selection Superior Gold"Premium retail and foodserviceRelaunch per IBISWorld enterprise profile (date not disclosed)
Tasmanian SmokehouseSmoked salmon products (hot- and cold-smoked)Retail deli and gourmetListed among Tassal brands in Fish Farmer, Nov 2022
Value-added and ready-to-cook salmonMarinated portions and meal-solution formatsConvenience retailSpecific SKUs and launch dates not publicly disclosed
Export salmonWhole fish and fillets for Asian marketsImporters and distributorsExport share was 20.3% of sales in 1H FY2020

Key specifications. Average harvest size was 4.52 kg HOG in FY2020, versus 4.39 kg in FY2019 (Kalkine, citing company reports). Larger fish improve processing yields and domestic pricing. Sustainable harvest from existing leases was described as about 40,000 HOG tonnes per year in 1H FY2022.

Prawns

Brand / lineDescriptionTarget customerNotes
Tropic Co – The Aussie PrawnAustralian black tiger prawns (Penaeus monodon): cooked, raw, whole and peeled formatsRetail and foodserviceGrown at Queensland and northern NSW pond farms. Capacity about 5,500 t from two hatcheries, three pond farms and processing facilities (Fish Farmer, Nov 2022)

Sites referenced in company disclosures include Proserpine and Mission Beach (Queensland), Yamba (NSW) and Billy Creek (acquired Nov 2020). Tassal's selective breeding programme for prawns was initiated by 2019.

Barramundi

Brand / lineDescriptionTarget customerNotes
Tassal Barramundi (ocean-farmed, Western Australia)Ocean-grown barramundi from Cone Bay, Kimberley regionRetailMPA acquisition completed Aug 2023. About 1,600 t/yr. Tassal-branded barramundi scheduled to reach market in Nov 2023

Seafood distribution and retail

Brand / businessDescriptionTarget customerNotes
De Costi SeafoodsSeafood processor, wholesaler and retailer in Sydney (Lidcombe, NSW); distributes Tassal salmon and prawns plus third-party seafoodRetail, wholesale, foodserviceAcquisition announced 1 Jul 2015
Cooke Seafood (Australia)Cooke group seafood products marketed in AustraliaRetail and foodserviceListed as a Tassal-operated brand by IBISWorld; scope not publicly disclosed

Pricing model. Tassal sells on negotiated retail supply agreements and spot or contract wholesale and export pricing. Domestic retailers accepted cost-driven price increases in FY2022 (company commentary reported by SalmonBusiness). Specific price lists are not publicly disclosed.

Financial Narrative

Important: Tassal has not published financial statements since FY2022. FY2023–FY2026 figures are not publicly disclosed.

Income statement

Sources and derivations:

  • FY2022: Annual Report 2022 and FY22 results release (16 Aug 2022). Statutory EBITDA +35.7%; statutory NPAT +59.9%; operating EBITDA +25.3%; operating NPAT +31.9%.

  • FY2021 derived from FY2022 growth rates: statutory EBITDA 162.6/1.357; statutory NPAT 55.4/1.599; operating EBITDA 174.5/1.253; operating NPAT 63.7/1.319.

  • FY2020: Annual Report 2020 and Kalkine. Operating EBITDA A$138.55m (+23.4%); statutory EBITDA A$145.61m (+26.7%); statutory NPAT A$69.11m (+18.3%); operating NPAT A$64.17m (+13.3%).

  • FY2019: Annual Report 2019 and Kalkine. Revenue A$560.8m; operating NPAT A$56.6m (+12.5%); statutory NPAT about A$58.4m. FY2019 EBITDA figures are derived from FY2020 growth rates. Operating EBIT of A$88.55m (+15.4%) per SalmonBusiness.

  • FY2018: revenue from all sources per Annual Report 2019 comparative; operating NPAT derived (56.6/1.125).

Not reported: Gross profit and pre-tax income were not reported in a form verifiable from the sources reviewed (Tassal reported EBITDA-centric metrics). FY2022 had an 8c interim, and the scheme price assumed no FY2022 final dividend.

Margins (%)

Margins are calculated from the table above. Kalkine separately cites an FY2020 EBITDA margin of 22.6%, presumably on a different revenue base.

Revenue CAGR. FY2018–FY2022 compound annual growth was about 12.9% (484.5 to 788.7 over four years). Kalkine reported a 2016–2020 revenue CAGR of 6.76% and a 2015–2019 CAGR of about 16%.

Cash flow

Sources: FY2022 from Annual Report 2022 (OCF +127.8%; FCF A$95.4m vs A$29.5m; FCF after investing A$62.7m inflow vs A$44.6m outflow). FY2021 OCF derived (139.03/2.278). FY2019 A$89.9m (+104.9%) and FY2020 A$49.85m (−44.5%) per Kalkine and Food & Drink Business. FY2018 derived.

Capex. Not separately verified by year. The Annual Report 2022 states that capital investment from FY2018 to FY2021 totalled about A$420m. Guidance for FY2021 total capex was about A$125.1m (Kalkine).

Balance sheet

Aggregator claim: roic.ai states Tassal secured an A$497m sustainability-linked loan in 2022.

Ratios

FY2019 operating ROA of 10.3% is per Kalkine; the 1H19 investor presentation shows 10.6%, excluding prawns. Net debt/EBITDA is calculated as 333.3/174.5. The 10.0x EV/EBITDA figure is per the SID announcement.

ROE, ROIC, current ratio, interest coverage, asset turnover and the cash conversion cycle are not publicly disclosed or verified. The company itself noted that operating ROA and ROIC fell in FY2020 because of heavy strategic capital investment.

Commentary on trends and inflections

FY2018–FY2019: volume-led growth. Revenue grew 15.7% and salmon revenue 19.9%. Salmon harvest rose 7.0% to 33,036 HOG t, and sales volumes rose 10.3% to 33,856 t (SalmonBusiness, FY19 results).

FY2020: margin over volume. Revenue was flat (+0.3%). Operating EBITDA nonetheless rose 23.4% as EBITDA per kg climbed 14%, helped by larger fish and a deliberate shift toward domestic sales. Cash conversion collapsed (OCF −44.5%) because Tassal deliberately built salmon and prawn biomass and inventory.

FY2021: COVID trough. Export prices fell sharply and Tassal had to fund export freight (about €6.1m of extra freight cost in 1H21). Statutory NPAT roughly halved to about A$34.6m. Operating EBITDA held about flat, which shows the biomass build continued.

FY2022: step change. Revenue jumped 32.8% to A$788.7m. Drivers were salmon volume (about 40,000 t), historically high global salmon prices, domestic retail price pass-through, Asian export leverage, and prawn harvests roughly doubling. The investment phase ended (about A$420m invested over FY2018–FY2021) and free cash flow turned decisively positive. That inflection is what Cooke paid for, at about 10x FY2022 EBITDA.

Post-FY2022. Not publicly disclosed. The operating evidence points to a harder environment from FY2025: flat Tasmanian volumes (33,523 t in FY2025 and 33,388 t in FY2026, well below the roughly 40,000 t capacity cited in 2022), mass mortalities and antibiotic constraints. It would be unsafe to infer financial figures.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Revenue by Segment

SegmentFY2018FY2019FY2020FY2021FY2022

Salmon revenue (AUD Mn)

395.47474.03—470.54610.92

Prawn revenue (AUD Mn)

—9.141.4——

Total group revenue, all sources (AUD Mn)

484.54560.79562.54593.9788.7

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Results by Segment and Unit Economics (AUD/kg)

MetricFY2019FY2020FY2021FY2022

Salmon EBITDA (AUD Mn)

——120.03146.59

Salmon EBITDA per kg (AUD)

3.163.603.203.40

Salmon revenue growth YoY (%)

19.9——29.8

Salmon EBITDA growth YoY (%)

14.5——22.1

Revenue by Segment (%)

MetricFY2018FY2019FY2021FY2022

Salmon share of group revenue (%)

81.684.579.277.5

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Income Statement and Margin Analysis (%)

MetricFY2018FY2019FY2020FY2021FY2022

Revenue, all sources (AUD Mn)

484.54560.79562.54593.9788.7

Revenue growth YoY (%)

—15.70.35.632.8

Statutory EBITDA (AUD Mn)

—114.9145.61119.8162.6

Operating EBITDA (AUD Mn)

—112.3138.55139.3174.5

Operating EBIT (AUD Mn)

—88.55———

Statutory NPAT (AUD Mn)

—58.469.1134.655.35

Operating NPAT (AUD Mn)

50.356.664.1748.363.69

Dividends per share (A$ cents)

161818——

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Margin Analysis (%)

MetricFY2019FY2020FY2021FY2022

Statutory EBITDA margin (%)

20.525.920.220.6

Operating EBITDA margin (%)

20.024.623.522.1

Statutory net margin (%)

10.412.35.87.0

Operating net margin (%)

10.111.48.18.1

Cash Flow

MetricFY2018FY2019FY2020FY2021FY2022

Operating cash flow (AUD Mn)

43.989.949.8561.0139.03

Free cash flow, OCF less maintenance capex (AUD Mn)

———29.595.4

Free cash flow after investing activities (AUD Mn)

———-44.662.7

Key Financials

MetricFY2022

Net debt at 30 June (AUD Mn)

333.3

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2019FY2022

Operating ROA (%)

10.3—

Net debt / operating EBITDA (x)

—1.9

Takeover EV / FY2022 EBITDA (x)

—10.0

Revenue by Region (%)

MetricFY2019FY2020

Domestic salmon sales volume (HOG t)

26,86028,259

Export share of total sales, 1H FY2020 (%)

—20.3

Valuation Snapshot

MetricValueDateSource

Undisturbed share price (AUD)

3.52

22 Jun 2022

SID announcement

Scheme consideration (A$/share)

5.23

Nov 2022

ASX

Premium to undisturbed price (%)

49

Aug 2022

ASX

Equity value at scheme (AUD Bn)

1.1

Aug 2022

ASX

Enterprise value at scheme (AUD Bn)

1.7

Aug 2022

ASX

EV / FY22 EBITDA (x)

10.0

Aug 2022

ASX

Market capitalisation (AUD Mn)

726

1 Oct 2020

Kalkine

Market capitalisation (AUD Mn)

777

19 Nov 2020

Kalkine

Share price after 1H20 result (AUD)

4.50

12 Feb 2020

The Motley Fool

Per-Share Data

MetricFY2015FY2018FY2019FY2020FY2022

Total DPS (cents)

141618188

Analyst Conclusions

Guidance and consensus

  • No public guidance or consensus exists because Tassal is a private subsidiary.

  • Operational indicators to watch: summer 2026–27 mortality (EPA monthly data), the new florfenicol permit decision, and FY2027 harvest volumes (NRE portal).

Bull case

  1. Strong platform economics. FY2022 showed the platform can generate A$174.5m operating EBITDA and A$95.4m free cash flow once biomass and prices align. Cooke's capital and engineering could restore volumes toward 40,000 t.

  2. Diversification hedge. Prawns (historically about 2.5x salmon EBITDA/kg) and barramundi reduce dependence on Tasmanian inshore salmon.

  3. Political backing. Bipartisan support (the 2025 EPBC amendment and the A$18.3m oxygenation programme) lowers the risk of forced closures.

Bear case

  1. Structural disease and climate risk. Endemic P. salmonis combined with warming seas makes disease a recurring cost. Tassal's own data imply roughly 23% more mortality per 1°C of warming.

  2. Shrinking treatment toolkit. The florfenicol suspension and the injection-only alternative are labour-intensive, while community and export-industry opposition is intensifying.

  3. Competitive and regulatory squeeze. Huon has overtaken Tassal, and growing pressure for offshore relocation implies heavy capex with uncertain returns.

Catalysts and monitorables (next 12 months)

  • Summer 2026–27 marine heatwave impact and mortality figures (EPA monthly releases).

  • APVMA ruling on the new florfenicol permit application by Salmon Tasmania.

  • Outcome of the Animals Australia complaint.

  • Legal challenges over Macquarie Harbour and Maugean skate monitoring.

  • FY2027 NRE production data (Tassal vs Huon).

  • Any Cooke disclosure on Australian investment (offshore pens, RAS), restructuring, or barramundi expansion.

  • Leadership succession after Mark Ryan's 23-year tenure.

Analyst verdict

Tassal is a high-quality but increasingly stressed asset. Its last public year, FY2022, showed what a fully invested Tasmanian salmon platform can produce when biology and prices cooperate: A$788.7m in revenue, A$174.5m operating EBITDA and a step change in free cash flow. Cooke paid a full but defensible multiple of about 10x EBITDA, a 49% premium, for scarce lease access, a dominant domestic brand position and a multi-species growth path.

Four years on, the investment case looks different. The core salmon business appears stuck at about 33,400 tonnes. That is well below the roughly 40,000 tonnes once described as sustainable, and Tassal has ceded volume leadership to JBS-owned Huon. The defining variable is no longer market price but biology. Piscirickettsia salmonis is now endemic in south-east waters, the 2025 industry mortality reached 20,133 tonnes, and the regulator removed Tassal's preferred antibiotic in March 2026 after residues reached wild export fisheries. Tassal's own climate disclosure concedes materially higher mortality with each degree of warming, and summer 2026–27 begins with seas already 2–3°C above normal.

Mitigants are real. Political support at both levels of government has neutralised the Macquarie Harbour threat for now. Prawns and barramundi provide margin diversification, and Cooke's balance sheet and global engineering capabilities allow investment through the cycle in a way a standalone ASX company could not.

On balance, Tassal remains a strategic franchise with sound long-run economics, but its near-term earnings power is likely impaired relative to FY2022. The direction of travel will depend on whether Cooke funds a decisive shift toward higher-energy, offshore or RAS-supported production. Absent such a shift, recurring summer mortality, regulatory tightening and social-licence erosion are likely to cap value. Because no financial statements have been published since FY2022, any valuation view should be treated as provisional until Cooke or Tassal discloses current figures.


Primary and secondary sources referenced:

  • Tassal ASX announcements: Annual Reports 2019, 2020 and 2022; 1H FY22 results; SID announcement (16 Aug 2022); scheme implementation (21 Nov 2022); Goldman Sachs Emerging Leaders Conference presentation (Apr 2019)

  • Cooke Inc. press releases (Aug 2022, Nov 2022, Aug 2023)

  • APVMA statements (Feb–Mar 2026); Tasmanian NRE florfenicol page

  • ABC News; Pulse Tasmania; SalmonBusiness; Fish Farmer; Fish Farming Expert; Undercurrent News; SeafoodSource

  • Food & Drink Business; Business News Australia; The Examiner / Stock & Land; Canberra Times; Tasmanian Times; Tasmanian Country; Port News

  • Mirage News (UTS ISF report); Business & Human Rights Resource Centre; Tasmanian Greens media releases; Rosemary Armitage MLC motion

  • Aggregators: Kalkine; IBISWorld; Simply Wall St; MarketScreener; roic.ai; FAIRR; Wikipedia

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleTenureBackgroundSource

Mark Andrew Ryan

Managing Director & CEO, Tassal; Managing Director, Aquaculture Australia Holdco Pty Ltd

CEO since Nov 2003 (about 23 years)

B.Com, University of Tasmania (1994); Chartered Accountant; former partner at KordaMentha; former Chair, Macquarie Point Development Corporation; former director of Bellamy's Australia and the AFL; director roles include SALTAS, Tasmanian Salmonid Growers Association, Seafood Industry Australia, AFL Tasmania and the Institute for Marine & Antarctic Studies

MarketScreener; Simply Wall St; IBISWorld; Annual Report 2022

Glenn Cooke

Director, Tassal (from 21 Nov 2022); CEO, Cooke Inc.

Since Nov 2022

Co-founder and CEO of the Cooke family of companies

ASX announcement, 21 Nov 2022

James Trask

Director, Tassal (from 21 Nov 2022)

Since Nov 2022

Cooke group nominee; further details not publicly disclosed

ASX announcement, 21 Nov 2022

Mark Asman

Head of Aquaculture (as listed in the 2020 and 2022 Annual Reports)

Long-serving

—

Annual Reports 2020, 2022; Undercurrent News

Board of Directors — James Fazzino

NameRoleAppointedNotes

James Fazzino

Independent Chair

Director 29 May 2020; Chair 28 Oct 2021

B.Ec (Hons), CPA

Richard Haire

Independent Non-Executive Director

5 Mar 2020

B.Ec, FAICD

Georgina Lynch

Independent Non-Executive Director

——

Jackie McArthur

Independent Non-Executive Director

——

Kathy Parsons

Independent Non-Executive Director

29 Oct 2021

B.Com, ACA

John Watson

Non-Executive Director

——

Mark Ryan

Managing Director & CEO

Nov 2003

—

Major Shareholders

HolderStake (%)Date / note

Aquaculture Australia Company Pty Ltd (Cooke Inc.)

100

Since 21 Nov 2022

Cooke pre-scheme stake (excluded from scheme vote)

10.5

Aug 2022

Yarra Capital (sold just under 5% block that Cooke acquired)

—

Jun 2022

Competitive Landscape

Key Competitors

CompetitorOwnerSegment overlapPositioning vs Tassal

Huon Aquaculture

JBS (Brazil), acquired 2021 for about A$425m

Tasmanian salmon

Now the largest Tasmanian producer (34,588 t in FY2026); invested in offshore "fortress pens" and Storm Bay; RSPCA certification later withdrawn

Petuna Aquaculture

Sealord (New Zealand)

Tasmanian salmon (Macquarie Harbour, north-west)

Third producer (6,272 t in FY2026); Tassal's Macquarie Harbour JV partner

Imported salmon (Norway and others)

Various

Domestic salmon

Price competitor when supply is short

Mowi

Listed (Oslo)

Global salmon (export markets)

Global price-setter

SalMar

Listed (Oslo)

Global salmon

Export competitor

Lerøy Seafood

Listed (Oslo)

Global salmon

Export competitor

Cermaq

Mitsubishi Corporation

Global salmon

Export competitor

New Zealand King Salmon

Listed (NZX/ASX)

Premium salmon in Australia

Premium niche competitor

Australian prawn farmers (e.g., Pacific Reef Fisheries, Gold Coast Marine Aquaculture)

Private

Farmed prawns

Domestic prawn rivals

Imported prawns (Vietnam, Thailand, etc.)

Various

Prawns

Price competition

Australian barramundi farmers (e.g., Humpty Doo Barramundi, Mainstream Aquaculture)

Private

Barramundi

Domestic rivals in the new species

Wild-catch seafood suppliers

Various

Retail seafood protein

Substitutes

Peer Comparison

ProducerFY2025FY2026

Tassal (t)

33,52333,388

Huon Aquaculture (t)

27,32134,588

Petuna (t)

7,1396,272

Tasmania total (t)

67,98474,249

Tassal share (%)

49.345.0

Peer Comparison FY2022

MetricTassal FY2022Huon 1H FY2021

Revenue (AUD Mn)

788.7220.1

Revenue growth (%)

32.824

Statutory NPAT (AUD Mn)

55.35-95.3

Company Snapshot

1,712

Employees

1986

Founded

Hobart, Australia

Headquarters

SWOT Analysis

Strengths

  • Scale. About 33,400 HOG t of Tasmanian salmon in FY2026, 45% of state output, plus about 5,500 t prawn capacity and about 1,600 t barramundi.
  • Proven earnings power. FY2022 revenue of A$788.7m, operating EBITDA of A$174.5m, and operating cash flow of A$139.0m (+128%).
  • Completed investment cycle. About A$420m invested in FY2018–FY2021, delivering FY2022 free cash flow of A$95.4m.
  • Vertical integration. Hatcheries, 18 marine licences, four processing sites in Tasmania, and the De Costi retail and wholesale channel.
  • Brand portfolio. Tassal, Tropic Co, De Costi, Superior Gold and Tasmanian Smokehouse.
  • Deep-pocketed parent. Cooke paid about A$1.7bn EV and runs a global network (11 countries, about 13,000 staff as of Nov 2022).
  • Management continuity. CEO Mark Ryan has led the business since 2003.

Weaknesses

  • Volume shortfall. FY2026 output of 33,388 t is about 17% below the roughly 40,000 t sustainable harvest cited in 1H FY2022.
  • Lost leadership. Huon's output rose 26.6% while Tassal's fell 0.4% in FY2026.
  • Antibiotic dependence. Tassal treated five leases with florfenicol on about the same day in February 2026, then shifted to OTC injections by October 2026.
  • Compliance history. 19 ASC non-conformances in Macquarie Harbour (2017); antibiotic residues in wild flathead after the 2022 vibrio outbreak; two Long Bay breaches.
  • Financial opacity. No public financial statements since FY2022.
  • Earnings volatility. Statutory NPAT fell about 50% in FY2021 because of export disruption.

Opportunities

  • Prawn margins. Prawn EBITDA per kg was described in 2019 as about 2.5x that of salmon.
  • Barramundi growth. Management flagged growth options once Cone Bay is consolidated.
  • Asian exports via Cooke. Cooke's global distribution channels; growing Chinese demand.
  • Offshore and high-energy farming. Storm Bay, plus a proposed offshore salmon commercial-scale trial in Australia.
  • New florfenicol permit. Salmon Tasmania intends to apply for a new permit in 2026 with measures to address export concerns.
  • Macquarie Harbour certainty. The 2025 EPBC amendment, the August 2025 ministerial reaffirmation and the A$18.3m oxygenation programme.

Threats

  • Climate cost. Tassal's own estimate is that 1°C of warming lifts mortality from 15 to 18.5 per 100 fish; ISF estimates about A$23.7m/yr.
  • Industry mortality. 20,133 t in 2025 and more than 9,000 t in Q1 2026.
  • Regulatory tightening. Weekly pen-level mortality reporting from 2026; APVMA suspension.
  • Cross-industry conflict. Rock lobster closures and abalone and lobster residue detections.
  • Litigation and complaints. Animals Australia welfare complaint (Sep 2026); environmental groups pledging to challenge Macquarie Harbour decisions.
  • Social licence. Shutdown calls, mass protests (Apr 2025), and opinion polling (Australia Institute: 58% favour stopping Macquarie Harbour farming).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Feb–Mar 2025 (context)Mass mortality at Huon and Tassal farms in the D'Entrecasteaux Channel from *P. salmonis*. More than 5,500 t was sent to waste facilities in February 2025, about 6% of annual state output ABC; The New DailySets the backdrop for all subsequent regulatory action
Mar 2025Salmon companies defend product safety; health officials confirm *P. salmonis* is not a human health risk ABC, 22 Mar 2025Brand and reputation defence
Late Mar–Apr 2025EPBC Amendment (Reconsiderations) Act 2025 passes with Coalition support, protecting Macquarie Harbour farming ABC, 27 Apr 2025Removes an existential risk to Tassal's west-coast leases
27 Apr 2025Large protest at Tasmanian Parliament House against farmed salmon ABCSocial licence pressure during the federal election
Apr 2025IPA paper disputes the link between salmon farms and Maugean skate decline Fish Farming ExpertContested science
14 Aug 2025Minister Watt reaffirms 2012 Macquarie Harbour expansion decision; A$18.3m oxygenation funding ABC; Tasmanian TimesRegulatory certainty; environmental groups vow challenge
Nov 2025APVMA grants emergency florfenicol permit (PER96499); two rock lobster fishery zones closed in response APVMA; Canberra TimesDisease tool for Tassal; cross-industry conflict
Nov–Dec 2025Mortality rises with warm water: about 500,000 fish lost in Nov–Dec; more than 40 t/day in December SalmonBusiness, Jan 2026Summer disease cycle confirmed as structural
Jan 2026EPA data: 2025 Tasmanian salmon mortality totalled 20,133 t (about 4 million fish) SalmonBusiness; Fish Farming ExpertScale of industry losses quantified
24 Jan–2 Feb 2026Tassal feeds florfenicol-coated pellets at its GTB2 lease Fish Farming ExpertActive disease management
Feb 2026Monthly public mortality disclosure begins; weekly pen-level reporting directed under the Biosecurity Act Mirage News; Pulse TasmaniaTransparency obligations rise
18–20 Feb 2026APVMA proposes to suspend florfenicol permit after detections in wild abalone and lobster more than 10 km from leases APVMA; Tasmanian CountryThreatens Tassal's main disease tool
~22 Feb 2026Tassal begins florfenicol treatment at five leases on the same day; says it is fully within permit terms Tasmanian Greens; Tasmanian CountryPolitical backlash (Greens)
4 Mar 2026APVMA suspends permitLoss of the preferred treatment
24 Mar 2026Budget Estimates evidence: more than 800 kg of florfenicol used in three weeks; Tassal application for Okehampton Bay noted Legislative CouncilScrutiny escalates
17 Apr 2026EPA data: Q1 2026 mortality more than 9,000 t (Jan 2,025 t; Feb 3,356 t; Mar 3,816 t), about a third below Q1 2025 Pulse TasmaniaOngoing high losses
22 Apr 2026Salmon Tasmania launches campaign; environmental group calls for shutdown; EPA residue monitoring at Tassal leases ABC; Business & Human Rights CentreReputation battle
Apr 2026Reports that florfenicol was still detectable at two Tassal leases two months after use (ABC later corrected this) Tasmanian Greens; ABC editor's noteEnvironmental residue concern
4 Aug 2026EPA grants Long Bay lease a two-year extension; two "short-lived and rare" breaches noted ABCRetains a contested lease
7–8 Sep 2026Animals Australia lodges an animal welfare complaint against Huon, Tassal and Petuna; industry calls the allegations recycled and false ABCLegal and regulatory risk
10 Sep 2026Huon overtakes Tassal: FY2026 Tassal 33,388 t (−0.4%) vs Huon 34,588 t (+26.6%) SalmonBusinessLoss of leadership position
–Former Tassal Head of Aquaculture Mark Asman reported to have died Undercurrent News headlineLoss of a veteran
6–8 Oct 2026Tassal starts at-sea OTC injections at Great Taylors Bay because of early disease onset; awaiting a new florfenicol permit ABC; Pulse Tasmania; Undercurrent NewsNew treatment approach before summer
14 Oct 2026UTS ISF report estimates 1°C of warming could cost Tassal about A$23.7m/year in dead salmon; seas 2–3°C above average with severe heatwaves forecast to Christmas Port News; Mirage NewsQuantifies climate risk heading into summer

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Revenue by Segment: Total group revenue, all sources rose from AUD 484.5 Mn in FY2018 to AUD 788.7 Mn in FY2022.
Tassal Group Limited — Revenue by Segment
Series (AUD Mn)FY2018FY2019FY2020FY2021FY2022
Total group revenue, all sources484.5560.8562.5593.9788.7
Salmon revenue395.5474—470.5610.9
Prawn revenue—9.141.4——

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.